The Chief Government Officer (CEO) of the corporate is the topic of a criticism from a Drug Regulatory Authority of Pakistan (DRAP) officer who claims that he’s the proprietor of an unnamed pharmaceutical firm, which creates a battle of curiosity.
CEO Asim Rauf refuted the accusations and warranted the criticism will face harsh punishment. Comparable claims have been made prior to now towards former DRAP CEOs, however none of them have been confirmed.
In a letter, Dr. Mohammad Aleem Akhter, the deputy director of DRAP in Quetta, alleged that the CEO had been performing improperly ever since his 2002 appointment. The letter claimed that Rauf had damaged research depart insurance policies by enrolling in a Ph.D. programme in america after solely two years on the job, in need of the necessary 5 years of service. He was additionally charged with working M/s Zeta Prescription drugs in Lahore in violation of the DRAP Act of 2012.
The paperwork are connected, they usually present that Rauf began the enterprise in 2010 below his brother’s title earlier than giving it to his father-in-law in 2018. The letter additionally acknowledged that there was a second companion within the enterprise, and that the property would go to the CEO’s property within the occasion of his passing.
The officer who made the criticism requested for an investigation to do away with fraud and irregularities. The top of DRAP, nonetheless, asserted that the complainant had a historical past of creating unfounded accusations and vowed to take authorized motion towards him.
The Ministry of Nationwide Well being Companies’ Sajid Shah agreed that related claims had been made prior to now however that none had been verified. He emphasised the ministry’s dedication to transparency and rule compliance inside DRAP and expressed his perception that sure people each inside and out of doors of DRAP have been exerting stress on CEOs.
